Kao G - Search Results

1

The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.

Harris EE, Hwang WT, Lee EA, Cengel KA, Feldman MD, Demichele A, Kao G, Solin LJ. Harris EE, et al. Among authors: kao g. Breast J. 2006 Sep-Oct;12(5):431-6. doi: 10.1111/j.1075-122X.2006.00297.x. Breast J. 2006. PMID: 16958961

2

A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.

D'Amico AV, Whittington R, Malkowicz SB, Schnall M, Tomaszewski J, Schultz D, Kao G, VanArsdalen K, Wein A. D'Amico AV, et al. Among authors: kao g. Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):293-302. doi: 10.1016/0360-3016(94)90007-8. Int J Radiat Oncol Biol Phys. 1994. PMID: 7928457

3

Potential applications of cell cycle manipulation to clinical response.

Harris EE, Kao GD, Muschel RJ, McKenna WG. Harris EE, et al. Among authors: kao gd. Cancer Treat Res. 1998;93:169-90. doi: 10.1007/978-1-4615-5769-2_8. Cancer Treat Res. 1998. PMID: 9513781 Review. No abstract available.

4

Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.

Lee EA, Keutmann MK, Dowling ML, Harris E, Chan G, Kao GD. Lee EA, et al. Among authors: kao gd. Mol Cancer Ther. 2004 Jun;3(6):661-9. Mol Cancer Ther. 2004. PMID: 15210851

5

Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents.

Dowling M, Voong KR, Kim M, Keutmann MK, Harris E, Kao GD. Dowling M, et al. Cancer Biol Ther. 2005 Feb;4(2):197-206. Epub 2005 Feb 8. Cancer Biol Ther. 2005. PMID: 15753652

6

Radiosensitizing effects of the prenyltransferase inhibitor AZD3409 against RAS mutated cell lines.

Cengel KA, Deutsch E, Stephens TC, Voong KR, Kao GD, Bernhard EJ. Cengel KA, et al. Cancer Biol Ther. 2006 Sep;5(9):1206-10. doi: 10.4161/cbt.5.9.3172. Epub 2006 Sep 11. Cancer Biol Ther. 2006. PMID: 16969121

7

Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells.

Cengel KA, Voong KR, Chandrasekaran S, Maggiorella L, Brunner TB, Stanbridge E, Kao GD, McKenna WG, Bernhard EJ. Cengel KA, et al. Neoplasia. 2007 Apr;9(4):341-8. doi: 10.1593/neo.06823. Neoplasia. 2007. PMID: 17460778 Free PMC article.

8

Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions.

Dorsey JF, Dowling ML, Kim M, Voong R, Solin LJ, Kao GD. Dorsey JF, et al. Cancer Biol Ther. 2010 May 15;9(10):809-18. doi: 10.4161/cbt.9.10.11453. Cancer Biol Ther. 2010. PMID: 20234172 Free PMC article.

9

Lack of compliance with national vaccination guidelines in oncology patients receiving radiation therapy.

Yee SS, Dutta PR, Solin LJ, Vapiwala N, Kao GD. Yee SS, et al. J Support Oncol. 2010 Jan-Feb;8(1):28-34. J Support Oncol. 2010. PMID: 20235421

10

Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study.

Frick MA, Kao GD, Aguarin L, Chinniah C, Swisher-McClure S, Berman AT, Levin WP, Cengel KA, DeCesaris C, Hahn SM, Dorsey JF, Simone CB 2nd. Frick MA, et al. Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):536-542. doi: 10.1016/j.ijrobp.2018.06.041. Epub 2018 Jul 2. Int J Radiat Oncol Biol Phys. 2018. PMID: 30244877 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

313 results

Search Page